Arcadia Biosciences, Inc. announced that the U.S. Patent and Trademark Office has awarded the company a patent for its high fiber resistant starch GoodWheat. The patent broadens Arcadia’s intellectual property estate to include short deletions that may be obtained with CRISPR and similar genome editing tools. This represents the 28th patent for Arcadia’s GoodWheat non-GMO wheat platform which provides unique consumer products with higher fiber, fewer calories, reduced gluten and extended shelf life.
“This newest patent further strengthens our position as a leader in crop innovation bringing value and nutritional improvements to wheat products, and ultimately to consumers,” says Matt Plavan, president and CEO of Arcadia. “Wheat is one of the most widely consumed crops in the world, and our GoodWheat portfolio offers incomparable functional benefits to food companies and health benefits to consumers with the same taste and texture as conventional wheat.”
Arcadia’s high fiber resistant starch GoodWheat varieties have eight times the total dietary fiber, with 30% fewer calories compared to conventional wheat varieties. The FDA recommends a total dietary fiber intake of 28 grams a day based on a 2,000 calorie diet, but Americans typically consume a daily average of only 16 grams of fiber.
Arcadia recently launched a premium line of GoodWheat pasta and flour products through a partnership with Three Farm Daughters. The company is also bringing its GoodWheat high fiber wheat to market in North America through a partnership with Bay State Milling and Arista Cereal Technologies, under Bay State’s HealthSense brand portfolio.
